Skye Bioscience Inc (SKYE)

[Closewatcher]

Been a month since last press release, biggest gap in 6 months. Reaaaaaaaly need some Fire to light this.

Amazing how undervalued this company is in relation to its peers. You would think that this should show a steady walk-up, considering the press releases from the December-March and the advancement towards trials. The round of funding in August 2015 was supposed to take NB1111 into trials, so we're almost pulling into 2 years now, bound to hear some developemnt.

InMed Pharma is trading at a 55million market cap with a pipeline that is incredible small, and well behind Nemus in timeline: https://www.inmedpharma.com/pipeline/